New Device May Revolutionize the Sleep Apnea Industry

Tuesday, January 01, 2002

Sleep Review Magazine

Innomed Technologies Inc, Boca Raton, Fla, recently introduced the FDA-approved Nasal Aire interface, helping the company receive sales commitments of more than $20 million. The device does not require a headgear, virtually eliminates all pressure points on the face and bridge of the nose, has one of the highest CO2 washouts, contains virtually no parts that can break from the device, and wears like an oxygen cannula.

Contracts are already signed with three distributors to market the Nasal Aire interface to the home care markets in the United States and abroad, as well as the domestic hospital market, and the company is in negotiations with numerous other international distribution networks.

According to analyst reports, the sleep apnea market is growing at a pace of 25% annually, with 40% of the market devoted to respiratory products, says Patrick Karem, CEO of Innomed Technologies. Furthermore, 150 physicians from across the country serve on Innomeds advisory board. These physicians have endorsed the product and have expressed great enthusiasm in getting this innovative device on the market and to patients in need. (800) 200-9842; www.innomedinc.com.